Haemonetics (HAE) earnings, Nov 5, 2026: EPS +6%, stock −2.6%
In brief
Haemonetics reported on Nov 5, 2026. Earnings per share changed +6% year over year, 4.6% above the estimate; revenue +9%. The stock opened with a −1.1% gap and closed the day −2.6% (Nov 5, 2026). The stock is now 6.0% below its 52-week high, +144.7% over 12 months.
EPS vs estimate+4.6%
EPS, YoY+6%
Revenue, YoY+9%
Gap · day−1.1% · −2.6%
EPS growth by quarter, YoY
Price reaction to earnings
| Report | Gap | Day |
|---|---|---|
| Aug 6, 2026 | +2.6% | +1.7% |
| Nov 5, 2026 | −1.1% | −2.6% |
Next-quarter estimates, ratings and the HAE chart are in the terminal.
Open the terminalFAQ
When is Haemonetics's next earnings report?
There is no new date in the data yet: companies announce it a few weeks ahead.
How did Haemonetics stock react to the report?
Opening gap −1.1%, day's result −2.6%.
Did Haemonetics's earnings grow?
Earnings per share rose 6% year over year.
What is an earnings gap?
The jump between the close before and the open after the report. A big gap up often means large buyers are revaluing the company.